GB/T 44586.1-2024
ActiveIn vitro diagnostic medical devices—Multiplex molecular testing for nucleic acids—Part 1:Terminology and general requirements for nucleic acid quality evaluation
体外诊断医疗器械 多重核酸分子检测 第1部分：核酸质量评价术语和通用要求
Application Summary AI generated
This standard defines terminology and establishes general requirements for evaluating the quality of nucleic acids used in multiplex molecular testing within in vitro diagnostic medical devices. It applies to manufacturers and laboratories developing or using multiplex nucleic acid tests, such as those for detecting multiple pathogens or genetic markers in clinical samples. The standard ensures consistent quality assessment of nucleic acid extracts, supporting reliable diagnostic results in healthcare settings.
Related Standards
GB/T 19634-2005
In vitro diagnostic test systems-General technical requirements for blood-glucose monitoring systems for self-testing
GB/T 47486-2026
General technical requirements for vasculature-on-a-chip
GB/Z 30154-2013
Medical laboratories―Guidance on laboratory implementation of GB/T 22576-2008
GB/Z 16886.22-2022
Biological evaluation of medical devices—Part 22:Guidance on nanomaterials
GB/Z 43280-2023
Medical laboratories—Practical guidance for the estimation of measurement uncertainty
GB/Z 43281-2023
Guidance for supervisors and operators of point-of-care testing(POCT) devices
GB/Z 44363-2024
Pyrogenicity—Principles and methods for pyrogen testing of medical devices
GB/Z 157-2026
In vitro diagnostic test systems—Requirements and recommendations for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by nucleic acid amplification methods
Transparency note: The application summary and key sentences on this page were automatically generated by AI from the standard's original text. This content has not been human-verified and should not be used for compliance or regulatory purposes. Always refer to the official standard document from the issuing authority.